Advanced stages of PD: interventional therapies and related patient-centered care
- PMID: 26138439
- DOI: 10.1007/s00702-015-1418-0
Advanced stages of PD: interventional therapies and related patient-centered care
Abstract
During the last decades, symptomatic treatment of motor symptoms of Parkinson's disease (PD) improved continuously and is reflected by long-range independency of the patient during the disease course. However, advanced stages of PD still represent an important challenge to patients, caregivers and treating physicians. In patients with advanced PD, interventional therapy strategies are increasingly applied. These device-related treatment strategies using pump-based continuous dopaminergic stimulation (CDS) or deep brain stimulation (DBS) opened new treatment options especially if motor complications predominate. Well-designed clinical studies on these interventional therapeutic approaches provided class 1 evidence for the efficacy of DBS and CDS in advanced PD and opened new perspectives for their use in earlier disease stages also. Therefore, careful selection of patients amenable to the (semi)invasive therapy options becomes more and more important and requires an interdisciplinary setting that accounts for (i) optimal patient information and awareness, (ii) selection of best individual treatment modality, (iii) training of relatives and caregivers, (iv) management of complications, and (v) follow-up care. Here, we address these topics by summarizing current state-of-the-art in patient selection, providing specificities of treatment options and troubleshooting, and defining steps towards an optimized patient-centered care. Interventional therapies pioneer in the area of individualized treatment approaches for PD, and may be complemented in the future by biomarker-based improved stratification and by closed-loop systems for adaptive therapeutic strategies. In the present review, we summarize the proceedings of an Expert Workshop on Parkinson's disease held on November 22, 2014 in Frankfurt, Germany.
Keywords: Apomorphine; Deep brain stimulation; Levodopa-carbidopa intestinal gel; Motor complications; Parkinson’s disease; Patient-centred care.
Similar articles
-
Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.J Neurosurg. 2016 Apr;124(4):908-16. doi: 10.3171/2015.4.JNS15173. Epub 2015 Oct 23. J Neurosurg. 2016. PMID: 26495947
-
Neuromodulation Options and Patient Selection for Parkinson's Disease.Neurol India. 2020 Nov-Dec;68(Supplement):S170-S178. doi: 10.4103/0028-3886.302473. Neurol India. 2020. PMID: 33318347 Review.
-
When the going gets tough: how to select patients with Parkinson's disease for advanced therapies.Pract Neurol. 2013 Jun;13(3):140-52. doi: 10.1136/practneurol-2012-000463. Epub 2013 Mar 13. Pract Neurol. 2013. PMID: 23487815 Review.
-
Advanced Parkinson's disease: clinical characteristics and treatment. Part II.Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Neurologia. 2013. PMID: 23880230 Review. English, Spanish.
-
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.J Neurol. 2013 Nov;260(11):2701-14. doi: 10.1007/s00415-012-6798-6. Epub 2013 Jan 5. J Neurol. 2013. PMID: 23287972 Free PMC article. Review.
Cited by
-
Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.Mov Disord Clin Pract. 2018 Jun 27;5(4):383-393. doi: 10.1002/mdc3.12630. eCollection 2018 Jul-Aug. Mov Disord Clin Pract. 2018. PMID: 30363427 Free PMC article. Review.
-
The impact of device-assisted therapies on the gut microbiome in Parkinson's disease.J Neurol. 2022 Feb;269(2):780-795. doi: 10.1007/s00415-021-10657-9. Epub 2021 Jun 15. J Neurol. 2022. PMID: 34128115
-
ROS networks: designs, aging, Parkinson's disease and precision therapies.NPJ Syst Biol Appl. 2020 Oct 26;6(1):34. doi: 10.1038/s41540-020-00150-w. NPJ Syst Biol Appl. 2020. PMID: 33106503 Free PMC article.
-
Classification of advanced stages of Parkinson's disease: translation into stratified treatments.J Neural Transm (Vienna). 2017 Aug;124(8):1015-1027. doi: 10.1007/s00702-017-1707-x. Epub 2017 Mar 24. J Neural Transm (Vienna). 2017. PMID: 28342083 Free PMC article. Review.
-
Update on the Management of Parkinson's Disease for General Neurologists.Parkinsons Dis. 2020 Mar 26;2020:9131474. doi: 10.1155/2020/9131474. eCollection 2020. Parkinsons Dis. 2020. PMID: 32300476 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical